Reata Pharmaceuticals, Inc. (Nasdaq:RETA) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. Reata’s two most advanced clinical candidates (bardoxolone methyl and omaveloxolone) target the important transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
Pronnounced /ree-AH-tah/
Location: United States, Texas, Irving
Employees: 201-500
Phone: +1 972-865-2219
Total raised: $583M
Founded date: 2002
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.11.2019 | - | $505M | - |
| 12.07.2010 | - | $78M | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 08.08.2022 | Reata continues to hit FDA roadblocks with its Friedrei... | Reata Pharmaceuticals is facing an FDA wall on its small molecule candidate to treat Fried... | endpts.com... |
| 08.11.2021 | REATA PHARMACEUTICALS, INC. ANNOUNCES THIRD QUARTER 2021 FIN... | REATA PHARMACEUTICALS, INC. ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS AND PROVIDES AN UPDATE ON... | marketscre... |
| 29.10.2021 | Reata Pharmaceuticals Submits Marketing Authorization Applic... | Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced its submission of... | aithority.... |
| 08.06.2021 | REATA PHARMACEUTICALS, INC. Reata Pharmaceuticals : 2021 ER... | Master title style Safety of Bardoxolone Methyl in Pediatric Patients with Alport Syndrome in CARDIN... | marketscre... |
| 20.05.2021 | REATA PHARMACEUTICALS, INC. Reata Pharmaceuticals : Announc... | PLANO, Texas - Reata Pharmaceuticals, Inc. (Nasdaq: RETA) ('Reata,' the 'Company,' or 'we'), a clini... | marketscre... |
| 02.03.2021 | Reata Pharmaceuticals : Submits NDA for Company's Lead Progr... | PLANO - Reata Pharmaceuticals, Inc. (Nasdaq: RETA) ('Reata,' the 'Company,' or 'we'), a clinical-sta... | marketscre... |
| 15.10.2019 | Reata to seek approval for Friedreich’s ataxia drug on posit... | The company said that patients treated with the drug at 150mg per day showed a statistically signifi... | medcitynew... |
| 11.04.2016 | Top 10 Most Valuable Healthcare Startups | It's no secret that healthcare startups are hot right now. There are a lot of innovative companies o... | tech.co/ne... |
| 04.01.2016 | Biotech Startups Hit the Ground Running, With Six Filing IPO... | If we had to gamble on it, we’d bet the IPO market will be far more brisk this year than last year, ... | techcrunch... |
| 13.10.2010 | Healthcare VC deals tick up during the third quarter | Healthcare-related startups in search of cash have more to be happy about these days as venture capi... | massdevice... |
Show more